Inhibition of endocannabinoid degradation rectifies motivational and dopaminergic deficits in the Q175 mouse model of Huntington’s disease

Dan P. Covey, Hannah M. Dantrassy, Samantha E. Yohn, Alberto Castro, P. Jeffrey Conn, Yolanda Mateo, Joseph F. Cheer

Neuropsychopharmacology · 2018 · 33 citations · 42 references

Concepts

References

42